- Year founded 2000
- 67 Employees (site)
- Turnover: 5m - <10m EUR
Products/services: Aurigon Life Science is an independent privately-owned contract research institute dedicated to preclinical services for human and veterinary pharmaceuticals, food and chemicals. Aurigon provides a full range of advisory and experimental services in pharmacology, bio-/analytics and toxicology. From early-phase product efficacy and safety evaluation to regulatory toxicology and late-stage pre-marketing testing, we cover all areas of non-clinical drug development.
Planegger Str. 9A
PC / City
+49 (0)89 780 7200 10
Aurigon Life Science is an independent contract research organization (CRO) which perfoms preclinical research and development. The main emphasis of the company is the combination of pharmacological studies and toxicological testing in accordance with international and national requirements (BfArM, EMEA, FDA, ICH, OECD, GLP). Aurigon offers an integrated service from strategic planning of the preclincal development continuing with the pharmacological characterisation and toxicological testing of the sponsors substance up to the preparation of expert reports for the legal authorities. This includes a comprehensive range of in house services in the fields of preclinical efficacy and safety testing for biotechnology and pharmaceutical companies and the chemical industry.
Key sectors / sub-sectors
- Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
- Biotechnology: Preclinical development
- Other research and experimental development on natural sciences and engineering 72.19
- Research and experimental development on biotechnology 72.11
Sales markets - target industries
Sales markets - target countries